GSC
DARE icon

Ground Swell Capital’s Dare Bioscience DARE Stock Holding History

Ground Swell Capital’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2
Closed -$2K – 2455
2014
Q2 		$2K Buy
+2
New +$1.54K ﹤0.01% 1467

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ground Swell Capital's DARE Position: Q3 2014 in Review

Ground Swell Capital sold out of Dare Bioscience (DARE) in Q3 2014, closing a stake of 2 shares — an estimated $2K sold.

Ground Swell Capital first reported a position in DARE in Q2 2014 and held it in 1 quarter. The position peaked at $2K in Q2 2014. 15 funds tracked by Wall St. Rank hold DARE as of Q3 2014.

  • Ground Swell Capital reported no remaining Dare Bioscience position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 2 Dare Bioscience shares in Q3 2014, an estimated $2K.
  • Ground Swell Capital first reported a position in Dare Bioscience in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Dare Bioscience position peaked at $2K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.